23/10/2017 - 11:20 StockMarketWire
Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and raised its price target to 300p (from 2...
23/10/2017 - 08:51 StockMarketWire
Ergomed has announced positive top-line results from its phase II clinical trial of PeproStat, the company's potential first-in...
23/10/2017 - 06:00 RNS
Miscellaneous medium priority announcements
12/10/2017 - 15:48 RNS
Notification of major interests in shares
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment